Skip to content

SION SION Investing Cash Flow

Investing Cash Flow at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-$431.9M-674%
AbbVie logo
AbbVieABBV
-$574M+21.9%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$23.82M-389%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$268.65M-1,092%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$94.46M+404%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
-$506.2M-3,665%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's investing cash flow?
SION (SION) reported investing cash flow of $24.82M in Q1 2026.
How has SION's investing cash flow changed year-over-year?
SION's investing cash flow increased by 117.6% year-over-year, from -$141.19M to $24.82M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.